On September 18, 2019 CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat age-related diseases and extend healthy lifespan, reported that its Chief Executive Officer, Steven Engle, will present at the 2019 Cantor Global Healthcare Conference, which is being held October 2-4 at the Intercontinental New York Barclay Hotel in New York City (Press release, CohBar, SEP 18, 2019, View Source [SID1234539618]). The conference features more than 200 innovative public and private companies offering insights into developing trends shaping healthcare today.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

CohBar Presentation: Friday, October 4th at 12:35 PM ET.

Webcast: The CohBar presentation may be accessed via webcast at the scheduled time, or following the presentation, by clicking this weblink, View Source